Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease are down significantly in all age groups, while rates of IPD caused by nonvaccine strains are modestly on the rise. Streptococcus pneumoniae, also called pneumococcus, is one of the most common causes of bacterial pneumonia and deadly bloodstream infections in the United States.